These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 10499867)

  • 1. Contribution of vasopressin to progression of chronic renal failure: study in Brattleboro rats.
    Bouby N; Hassler C; Bankir L
    Life Sci; 1999; 65(10):991-1004. PubMed ID: 10499867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal tubular and vascular urea transporters: influence of antidiuretic hormone on messenger RNA expression in Brattleboro rats.
    Promeneur D; Bankir L; Hu MC; Trinh-Trang-Tan MM
    J Am Soc Nephrol; 1998 Aug; 9(8):1359-66. PubMed ID: 9697657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasopressin contributes to hyperfiltration, albuminuria, and renal hypertrophy in diabetes mellitus: study in vasopressin-deficient Brattleboro rats.
    Bardoux P; Martin H; Ahloulay M; Schmitt F; Bouby N; Trinh-Trang-Tan MM; Bankir L
    Proc Natl Acad Sci U S A; 1999 Aug; 96(18):10397-402. PubMed ID: 10468619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective blockade of vasopressin V2 receptors reveals significant V2-mediated water reabsorption in Brattleboro rats with diabetes insipidus.
    Pouzet B; Serradeil-Le Gal C; Bouby N; Maffrand JP; Le Fur G; Bankir L
    Nephrol Dial Transplant; 2001 Apr; 16(4):725-34. PubMed ID: 11274265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasopressin and the pathogenesis of chronic renal failure.
    Brooks DP; Solleveld HA; Contino LC
    Br J Pharmacol; 1990 May; 100(1):79-82. PubMed ID: 2372662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [3H]AVP binding to rat renal tubular receptors during long-term treatment with an antagonist of arginine vasopressin.
    Mah SC; Whitebread SE; De Gasparo M; Hofbauer KG
    Peptides; 1988; 9(3):595-600. PubMed ID: 3420014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasopressin is involved in renal effects of high-protein diet: study in homozygous Brattleboro rats.
    Bouby N; Trinh-Trang-Tan MM; Coutaud C; Bankir L
    Am J Physiol; 1991 Jan; 260(1 Pt 2):F96-100. PubMed ID: 1992784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term regulation of urea transporter expression by vasopressin in Brattleboro rats.
    Shayakul C; Smith CP; Mackenzie HS; Lee WS; Brown D; Hediger MA
    Am J Physiol Renal Physiol; 2000 Apr; 278(4):F620-7. PubMed ID: 10751223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasopressin increases urinary albumin excretion in rats and humans: involvement of V2 receptors and the renin-angiotensin system.
    Bardoux P; Bichet DG; Martin H; Gallois Y; Marre M; Arthus MF; Lonergan M; Ruel N; Bouby N; Bankir L
    Nephrol Dial Transplant; 2003 Mar; 18(3):497-506. PubMed ID: 12584270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of V1- and V2-vasopressin (AVP) antagonists on the pressor, AVP and atrial natriuretic peptide responses to a hypertonic saline infusion in conscious anephric rats.
    Ota K; Kimura T; Inoue M; Funyu T; Shoji M; Sato K; Ohta M; Yamamoto T; Abe K
    Eur J Endocrinol; 1995 Jul; 133(1):127-32. PubMed ID: 7627334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of acid-base transporters by vasopressin in the kidney collecting duct of Brattleboro rat.
    Amlal H; Sheriff S; Faroqui S; Ma L; Barone S; Petrovic S; Soleimani M
    Am J Nephrol; 2006; 26(2):194-205. PubMed ID: 16699257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arginine vasopressin increases renal sodium excretion in the anesthetized rat through V1 receptors.
    Musabayane CT; Forsling ML; Balment RJ
    Ren Fail; 1997 Jan; 19(1):23-32. PubMed ID: 9044449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Desensitization of rat renal thick ascending limb cells to vasopressin.
    Elalouf JM; Sari DC; Roinel N; de Rouffignac C
    Proc Natl Acad Sci U S A; 1988 Apr; 85(7):2407-11. PubMed ID: 3353389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of water intake on the progression of chronic renal failure in the 5/6 nephrectomized rat.
    Bouby N; Bachmann S; Bichet D; Bankir L
    Am J Physiol; 1990 Apr; 258(4 Pt 2):F973-9. PubMed ID: 2184677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arginine vasopressin mediates the chloroquine induced increase in renal sodium excretion.
    Musabayane CT; Windle RJ; Forsling ML; Balment RJ
    Trop Med Int Health; 1996 Aug; 1(4):542-50. PubMed ID: 8765464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DDAVP (1-desamino-8-D-arginine vasopressin): an antagonist of the pressor action of endogenous vasopressin?
    Derkx FH; Man in 't Veld AJ; Jones R; Reid JL; Schalekamp MA
    J Hypertens Suppl; 1983 Dec; 1(2):58-61. PubMed ID: 6400119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of vasopressin in neurocardiogenic responses to hemorrhage in conscious rats.
    Imai Y; Kim CY; Hashimoto J; Minami N; Munakata M; Abe K
    Hypertension; 1996 Jan; 27(1):136-43. PubMed ID: 8591876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged stimulation of intrarenal V1 vasopressin receptors results in sustained hypertension.
    Szczepanska-Sadowska E; Stepniakowski K; Skelton MM; Cowley AW
    Am J Physiol; 1994 Nov; 267(5 Pt 2):R1217-25. PubMed ID: 7977848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of vasopressin V1 and V2 receptor antagonists on progressive renal failure in rats.
    Okada H; Suzuki H; Kanno Y; Yamamura Y; Saruta T
    Clin Sci (Lond); 1994 Apr; 86(4):399-404. PubMed ID: 8168333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tolvaptan as a tool in renal physiology.
    Miranda CA; Lee JW; Chou CL; Knepper MA
    Am J Physiol Renal Physiol; 2014 Feb; 306(3):F359-66. PubMed ID: 24305472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.